Senestech: Humane Pest Control
Senestech is a platform biotechnology company specializing in reproductive physiology. Our mission: Senestech aims to provide for the more humane treatment of animals, to improve the quality of human life, and to enhance environmental stewardship through global application of our animal fertility control technology. We are currently applying our revolutionary technology to the control of rats and mice in both agricultural and urban settings.
Brain State Technologies - AZ Bio Company of the Year | 2012 Finalist
Brain State Technologies has a mission statement that is three words: To Help People. The corporate headquarters is based in Scottsdale, AZ and has nearly 200 providers in 18 countries that have helped over 50,000 people. Lee Gerdes is the Founder and CEO of Brain State Technologies® and the creator of the breakthrough neuro-technology Brainwave Optimization with Real-Time Balancing™, which helps people of all ages and conditions to overcome cognitive, emotional, and physical challenges and is transforming and likely saving lives all over the world. The firm and its process have been featured on ABC, FOX, CBS, OWN, People, The New York Times, USA Today, PARADE, The Arizona Republic, BrainWorld, Frontiers in Neuroscience, and more. Brain State offers a non-invasive process versus using drugs or surgery for a wide range of applications to overcome cognitive, emotional, and physical challenges including sleep disorders, alcoholism, meth addition, and PTSD. Their work has resulted in the largest relational database of brain patterns on planet Earth. Brain State’s patent-pending procedure compares over 48,000 brain frequencies and its patented Relational Sound (Wave Aid) program provides for ongoing process support. Committed to serving our veterans, the company offers pro bono services to soldiers with debilitating symptoms of PTSD.
Paul Keim, Phd - 2012 Bioscience Researcher of the Year
Dr. Paul Keim is the Cowden Endowed Chair of Microbiology at Northern Arizona University (NAU), the Director of Pathogen Genomics at the Translational Genomics Research Institute (TGen) and research affiliate at Los Alamos National Laboratory (LANL). Dr. Keim’s research focuses on the advancement of forensics and genomics analysis of bacterial pathogens. You may know this globally recognized researcher as ” Doctor Anthrax” (a moniker he gained after 9-11) but there is a lot more to the work Dr. Keim and his team focus on every day.
Innovation Local Business Incubator Transforms Science Into Marketable Applications
Transforming Innovation into Business Northern Arizona Center for Entrepreneurship and Technology fosters business growth and economic vitality, creating high-quality jobs for the region. Partnering with a wide variety of non-retail, service, manufacturing, high technology, science and renewable energy firms, NACET offers a hands-on business incubation engagement program designed to transform innovation into viable companies. NACET’s powerful program matches great ideas with the appropriate resources. We not only link our client companies to specialty labs and equipment, intellectual property and capital resources, but we also create synergies through an extensive network of mentors, faculty, staff, interns and alumni from local businesses and academic institutions. Located on the burgeoning business campus near Buffalo Park in Flagstaff, Ariz., NACET offers a beautiful, state-of-the-art facility with affordable office and meeting space, administrative support services, fully-equipped laboratory space and advanced communications technology. NACET – Your Business Resource NACET’s extensive business acumen and resources could be the catalyst you need to transform your innovation into a viable company. Find out how we can help.
Flagship Biosciences - AZBio Company of the Year | 2012 Finalist
Flagship Biosciences provides quantitative tissue analysis services for pharmaceutical and medical device development. Flagship offers a broad range of tissue assessment options, achieved through a diverse set of approaches. Flagship Biosciences provides tissue analysis solutions to over sixty biotech, pharmaceutical, and medical device clients, with global programs in place for tissue-based companion diagnostics with three of the largest pharmaceutical companies in the world. Their sales grew 400% in 2011, and are on track to triple again in 2012. Flagship scientists published seven peer-reviewed articles in 2011, and filed 4 patent applications during the year. However, the largest development for Flagship was the acquisition of a histology and immunohistochemistry laboratory during the close 2011 which has added tissue procurement to complete their tissue-based analysis operations. Finally, the company’s image analysis technology won a best poster award at the Pathology Visions 2011 conference in San Diego, and a best presentation award at the Pathology Informatics 2011 meeting in Pittsburgh The company is currently working on a medical device spinout of their existing operations and expansion into Phoenix later this year. Committed to growing not only the company but also Arizona’s bioscience talent pool, the company currently utilizes many students from Northern Arizona University. Flagship Biosciences was honored in 2011 with the 2011 AZBio Fast Lane Award .
Leslie Boyer, MD 2013 Arizona Bioscience Researcher of the Year
In 2013, Dr. Leslie Boyer was been named one of 30 heroes of rare diseases by the Food and Drug Administration’s Office of Orphan Products Development. Her work includes a clinical studies program conducted throughout Arizona with protocols for placebo-controlled, double-blind trials, open-label studies, historical control studies, and the statewide STING project. She has coordinated phase 2 and phase 3 multicenter clinical trials of pit viper antivenom, developed the Antivenom Index, and participated in the establishment of the Pan-American Lymphotoxinology Taskforce. Boyer, who is a member of the UA’s BIO5 Institute, has focused her scientific career on venomous bites and stings, which are often unrecognized public health issues. She began by developing public education programs that offer poison and toxin emergency treatment advice. In 2004 and 2005, with an FDA Orphan Product grant, she led a team that conducted clinical studies leading to the marketing approval of the first scorpion antivenom – representing one of more than 40 products developed through orphan grant-sponsored research.
W.L. Gore and Associaties, Inc. the 2013 Arizona Bioscience Company of the Year
W.L. Gore & Associates was honored at the 2013 AZBio Awards as the Arizona Bioscience Company of the Year by the Arizona Bioindustry Association in recognition of the development of the extensive Gore Medical family of products including vascular grafts, endovascular and interventional devices, and surgical meshes by its world class team of innovators in Flagstaff and Phoenix. In this video you will learn about Gore and also gain insights on what we need to do together to continue our Arizona Bioscience Industry growth from Gore's Kurt Long.
Arizona Commerce Authority05/17/2013
AZ Innovation Challenge Video
The Arizona Innovation Challenge (AIC), powered by the Arizona Commerce Authority , awards the most money in the country for a technology commercialization challenge – $3 million ($1.5 million twice yearly) to the world’s most promising technology ventures. Awards range from $100,000 to $250,000 per company. The results? A big-time investment in the most talented entrepreneurs. Bringing to market products that are literally changing the way the world works. Driving wealth and job creation for the state of Arizona. Are you up for the Challenge?